Amphastar Pharmaceuticals Ownership | Who Owns Amphastar Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amphastar Pharmaceuticals Ownership Summary


Amphastar Pharmaceuticals is owned by 18.29% institutional investors, 24.30% insiders, and 57.42% retail investors. Blackrock is the largest institutional shareholder, holding 12.33% of AMPH shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.71% of its assets in Amphastar Pharmaceuticals shares.

AMPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmphastar Pharmaceuticals18.29%24.30%57.42%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.94M12.33%$237.70M
Blackrock funding, inc. /de5.49M11.68%$146.18M
Vanguard group2.63M5.60%$70.12M
Td asset management1.93M4.11%$51.48B
Dimensional fund advisors lp1.76M3.74%$46.79M
State street1.50M3.20%$39.99M
Fuller & thaler asset management1.35M2.88%$36.08M
Boston trust walden1.17M2.50%$31.26M
Epoch investment partners1.13M2.42%$30.22M
Geode capital management922.58K1.97%$24.59M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lam group130.80K2.16%$3.49M
Mesirow institutional investment management380.39K1.09%$14.12M
Bridge city capital136.26K0.97%$3.63M
Quantedge capital pte45.10K0.66%$1.20M
Summerhaven investment management38.20K0.59%$1.02M
Illumine investment management27.68K0.53%$737.59K
Denali advisors135.00K0.41%$3.60M
Systematic financial management lp423.11K0.27%$11.28M
Significant wealth partners20.58K0.27%$548.43K
Boston trust walden1.17M0.23%$31.26M

Top Buyers

HolderShares% AssetsChange
Millennium management868.55K0.01%612.00K
Arrowstreet capital, limited partnership392.31K0.01%311.07K
Clark capital management group283.67K0.05%283.67K
Algert global392.90K0.18%268.61K
Ubs group312.27K0.00%245.44K

Top Sellers

HolderShares% AssetsChange
Neuberger berman group---1.37M
Boston partners---423.07K
Granite investment partners---375.78K
Pacer advisors6.00K0.00%-320.10K
Boone capital management---316.56K

New Positions

HolderShares% AssetsChangeValue
Clark capital management group283.67K0.05%283.67K$7.56M
Denali advisors135.00K0.41%135.00K$3.60M
Rice hall james & associates129.34K0.19%129.34K$3.45M
Jefferies financial group89.23K0.01%89.23K$2.38B
Quantedge capital pte45.10K0.66%45.10K$1.20M

Sold Out

HolderChange
Financial gravity asset management-1.00
Sjs investment consulting-1.00
Jfs wealth advisors-3.00
Wealthtrak capital management-5.00
Nelson, van denburg & campbell wealth management group-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025104-55.93%8,585,305-72.26%180.42%45-65.91%47-33.80%
Jun 30, 2025237-2.47%32,613,359-1.94%691.43%13214.78%70-25.53%
Mar 31, 20255-98.12%1,063,934-97.00%20.04%3-97.50%2-98.02%
Dec 31, 2024261-7.45%35,408,7620.08%721.38%116-18.31%1007.53%
Sep 30, 20242802.94%35,359,6972.73%721.47%140-93-4.12%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.19M4.71%-
FullerThaler Behavioral Sm-Cp Eq R61.21M2.60%-
FullerThaler Behavioral Small-Cap Equity1.21M2.60%-
Vanguard Total Stock Mkt Idx Inv1.14M2.46%-25.35K
Vanguard US Total Market Shares ETF1.14M2.40%1.24K
TD U.S. Capital Reinvestment I920.14K1.93%-27.55K
iShares Russell 2000 ETF896.80K1.93%-
Neuberger Berman Genesis Inv794.66K1.65%-271.05K
Federated Hermes Kaufmann R615.00K1.26%-
Federated Hermes Kaufmann Small Cap A522.39K1.10%-31.39K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 25, 2025PRINS RICHARD K-Sell$113.25K
Nov 13, 2025Petersen Floyd F.-Sell$441.84K
Nov 03, 2025Petersen Floyd F.-Sell$12.63K
Oct 01, 2025Petersen Floyd F.-Sell$13.60K
Sep 02, 2025Petersen Floyd F.-Sell$15.49K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q3-3
2025 Q2-3
2025 Q1-2
2024 Q4-7

AMPH Ownership FAQ


Who Owns Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals shareholders are primarily institutional investors at 18.29%, followed by 24.30% insiders and 57.41% retail investors. The average institutional ownership in Amphastar Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Amphastar Pharmaceuticals falls below.

Who owns the most shares of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals’s largest shareholders are Blackrock (5.94M shares, 12.33%), Blackrock funding, inc. /de (5.49M shares, 11.68%), and Vanguard group (2.63M shares, 5.60%). Together, they hold 29.61% of Amphastar Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amphastar Pharmaceuticals?

Yes, BlackRock owns 12.33% of Amphastar Pharmaceuticals, totaling 5.94M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.7M$. In the last quarter, BlackRock decreased its holdings by -137K shares, a -2.25% change.

Who is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lam group is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.16% of its assets in 130.8K Amphastar Pharmaceuticals shares, valued at 3.49M$.

Who is the top mutual fund holder of Amphastar Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amphastar Pharmaceuticals shares, with 4.71% of its total shares outstanding invested in 2.19M Amphastar Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools